Home - Products - GPCR/G Protein - Glucagon Receptor - NNC 92-1687

NNC 92-1687

CAS No. 22903-37-3

NNC 92-1687( —— )

Catalog No. M34348 CAS No. 22903-37-3

NNC 92-1687 is a selective glucagon receptor antagonist that can be used to study type 2 diabetes.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	603	Get Quote
5MG	922	Get Quote
10MG	1121	Get Quote
25MG	1454	Get Quote
50MG	1822	Get Quote
100MG	2250	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

NNC 92-1687
Note

Research use only, not for human use.
Brief Description

NNC 92-1687 is a selective glucagon receptor antagonist that can be used to study type 2 diabetes.
Description

NNC 92-1687 is a selective glucagon receptor antagonist that can be used to study type 2 diabetes.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

GPCR/G Protein
Target

Glucagon Receptor
Recptor

Glucagon Receptor
Research Area

——
Indication

——

Chemical Information

CAS Number

22903-37-3
Formula Weight

300.33
Molecular Formula

C15H12N2O3S
Purity

>98% (HPLC)
Solubility

——
SMILES

S(CC(=O)C1=CC(O)=C(O)C=C1)C=2NC=3C(N2)=CC=CC3
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

LGD-6972

LGD-6972 (RVT 1502) is a novel potent, selective, orally bioavailable glucagon receptor (GCGR) antagonist.
NNC 92-1687

NNC 92-1687 is a selective glucagon receptor antagonist that can be used to study type 2 diabetes.
Taspoglutide

Taspoglutide is a glucagon-like peptide-1(GLP-1) agonist for treatment of type 2 diabetes.

Sign In Join Free